The Collaborative Model: How SARC Is Keeping Rare Cancer Research Moving Forward

Sarcoma research presents unique challenges. With more than 100 rare subtypes and relatively small patient populations, meaningful progress depends heavily on collaboration across investigators, academic medical centers, industry partners, and nonprofit organizations.

In conversation with Attain Partners Principal Istvan Fekete, Steven Young, President and CEO of SARC (Sarcoma Alliance for Research through Collaboration), shares how SARC’s investigator-driven consortium model is accelerating clinical trials, coupled with Attain Partners’ support in navigating increasing operational and regulatory complexity through an on-demand consulting model.

The discussion also highlights how Attain Partners supports SARC through a flexible, on-demand consulting model. By providing specialized expertise only when it’s needed, Attain Partners helps SARC reduce delays, improve operational efficiency, adapt to evolving regulatory requirements, and keep more of its resources focused on what matters most—advancing research and improving outcomes for patients living with sarcoma. 

Learn how you can support SARC’s mission.

Give

Attain Partners – Supporting the Teams Behind Clinical Research

Learn how Attain Partners helps research organizations strengthen clinical trial operations through specialized consulting and on-demand expertise.